Clinica's Medtech Ventures - No 12: mtm's p16 biomarker takes subjectivity out of cervical cancer screening
This article was originally published in Clinica
Executive Summary
Company: mtm laboratories Specialty area(s): Cervical cancer diagnostics Based in: Heidelberg, Germany Founded in: 1999 No. of employees:54 Total investment received to date: E41m from HBM BioVentures, HBM BioCapital, Heidelberg Innovation, Wellington Partners, mtm founders, Mannheim Holdings, Nexus Medical Partners, tbg and MBG Baden-Wurttemberg